VEGFA and neoplasm: Currently, many studies have shown that anti‐angiogenic agents could normalize tumor blood vessels, reverse VEGF‐mediated immunosuppression, and promote immune cell differentiation, thus enhancing the efficacy of immunotherapy, which has been clinically confirmed.55, 56